Deep Pharma Intelligence
The leading UK-based market intelligence agency focused on the emerging markets in the Pharmaceutical, Biotech, and Healthcare industries.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Deep Pharma Intelligence, a subsidiary of Deep Knowledge Group, is a specialized think tank focused on biotech innovation. The company operates in the biotechnology and pharmaceutical sectors, providing in-depth market intelligence, data analysis, and strategic advisory services. Their primary clients include pharmaceutical companies, biotech firms, research institutions, and investors looking to understand market trends and technological advancements in drug discovery and development.
Deep Pharma Intelligence leverages advanced data mining and visualization systems to produce comprehensive industry reports and interactive analytics tools. These tools offer detailed insights into high-growth areas such as artificial intelligence (AI) in drug discovery, oncology, and cancer vaccines. By analyzing vast amounts of data, they help clients make informed decisions about investments, research directions, and market opportunities.
The company’s business model revolves around selling detailed industry reports, offering subscription-based access to their analytics platforms, and providing bespoke advisory services. They generate revenue through report sales, subscription fees, and consulting engagements. Their reports cover various topics, including AI in drug discovery, pharmaceutical market trends, and the landscape of biotech companies.
In summary, Deep Pharma Intelligence is a key player in the biotech and pharmaceutical intelligence market, helping clients navigate complex data to make strategic decisions.
Keywords: biotech innovation, market intelligence, drug discovery, AI, oncology, cancer vaccines, data analysis, strategic advisory, pharmaceutical trends, biotech firms.